P-glycoprotein expression and transport activity are reduced at the
blood-brain barrier of hAPP mice. A, representative images of brain
capillaries isolated from 12-week-old wild-type and hAPP mice. Capillaries
were incubated with 2 μM NBD-CSA, a fluorescent
P-glycoprotein-specific substrate, for 1 h alone or with PSC833. B, specific
(PSC833-sensitive) luminal NBD-CSA fluorescence after image analysis of
brain capillaries. C, luminal fluorescein-hAβ42 fluorescence in
brain capillaries from wild-type and hAPP mice. D, luminal fluorescence of
the MRP-specific, fluorescent substrate, sulforhodamine 101, in brain
capillaries alone (control) or with mannitol (osmotic tight junction
disruptor), LTC4 (MRP inhibitor), NaCN (metabolic inhibitor),
PSC833 (P-glycoprotein inhibitor), RAP (LRP1 inhibitor), or FTC (BCRP
inhibitor). Data in B–D are mean ± S.E.M. for 10
capillaries from one preparation (pooled tissue from 10–20 mice
per group). Shown are arbitrary fluorescence units (scale
0–255). ***, significantly lower than control,
P < 0.001. E and F, Western blots for
P-glycoprotein (P-gp) (E) and LRP1, RAGE, and GLUT-1 (F) of brain capillary
membranes from wild-type and hAPP mice. β-Actin was used as
protein loading control (pooled tissue from 20 mice per group).